About CellAuto
Since 2017building the machines that make cells into medicine.
Shenzhen CellAuto Technology Co., Ltd. is the developer of the National Engineering Research Center for Key Generic Technologies of the Cell Industry, and a National High-Tech Enterprise. We build end-to-end intelligent manufacturing for cell and gene therapy and for radiopharmaceuticals.
Who we are
Innovative technology
A multidisciplinary R&D team spanning biotechnology, information technology and automation. CellAuto is a pioneer in the development and large-scale production of digital intelligent manufacturing lines for biopharmaceuticals in China, and the only domestic company with independent R&D and mass-production capability for fully automated radiopharmaceutical dispensing systems.
Proven in production
Our solutions have been adopted by leading institutions, helping customers increase production efficiency by more than 70% while strengthening regulatory compliance and keeping product quality consistent from batch to batch.
A global vision
The mission is to move biopharmaceutical manufacturing from manual operation to automated, intelligent and digital production, reducing occupational exposure while protecting manufacturing safety, compliance and product quality.
Intellectual property
Two hundred and nine filings,and the programmes behind them.
A portfolio built over eight years of designing the mechanisms, the control systems and the software that automated cell manufacturing actually needs.
Milestones
Eight years, one direction.
From a research laboratory with no product to a company whose systems run production lines in hospitals, CDMOs and pharmaceutical workshops.
Scroll sideways to move through the years
Platforms and partnerships
Co-established an intelligent, automated CDMO platform for cell therapeutics with Fujian Maternity and Child Health Hospital. Partnered with Qionghai Beike on an Advanced Intelligent Manufacturing Demonstration Base in Lecheng, Hainan. Awarded the Guangdong Key Special Project for High-end Medical Devices. Achieved ISO 9001 certification. Co-established an automated virology laboratory with the Chinese CDC, and an Orthopedic Clinical Translation Center with Shenzhen Pingle Orthopedic Hospital.
Clinical translation
Co-established the Joint Laboratory for Clinical Translation of Cell Therapy with Qianhai Shekou Free Trade Zone Hospital. Awarded the Key Special Project for Stem Cell Research and Organ Repair under the National Key R&D Program.
CellAuto Matrix
Undertook the national industrialisation project for integrated biotechnology and information technology engineering, and a major special project from the Ministry of Industry and Information Technology. Following the updated NMPA GMP guidelines for cell products, launched the AI-powered CellAuto Matrix for fully enclosed, continuous, automated manufacturing.
First radiopharmaceutical system
Participated in the press conference for China's 14th Five-Year Plan for Bioeconomy Development. Delivered China's first fully automated radiopharmaceutical dispensing system. Recognised as a National High-Tech Enterprise.
World first
Delivered the world's first fully automated intelligent cell manufacturing system with independent mesenchymal stem cell production capability. Selected as a 2021 Future Unicorn Enterprise.
National research centre
Initiated the planning and construction of the National Engineering Research Center for Key Generic Technologies of the Cell Industry.
National award
Received the Second Prize of the National Technological Invention Award, the year the United States published its Roadmap for Cell Manufacturing to 2030.
The first prototype
Introduced the world's first prototype of a fully automated intelligent cell manufacturing system, capable of end-to-end autonomous MSC processing.
Where it started
Established an R&D laboratory dedicated to fully automated intelligent cell manufacturing, and built the interdisciplinary automation, biotechnology and information technology team the company still runs on.
Where our systems are deployed
CellAuto works as an early partner in the clinical translation of biopharmaceuticals, as a leader in radiopharmaceutical manufacturing, and as a provider of intelligent pharmaceutical manufacturing solutions, delivering complete implementation of digital, intelligent and automated production lines across all three.
The systems wedesign and build.
Empowering lifethrough technological innovation.
We have built an integrated platform that brings cell technology, advanced intelligent manufacturing and quality inspection together, to make the route from laboratory to clinic compliant, efficient and traceable end to end.